Search for dissertations about: "secretory leukocyte protease inhibitor SLPI"
Showing result 1 - 5 of 10 swedish dissertations containing the words secretory leukocyte protease inhibitor SLPI.
-
1. Secretory Leukocyte Protease Inhibitor (SLPI) in the gastrointestinal tract in man
Abstract : Secretory leukocyte protease inhibitor is a 11.7 kDa acid stable serine protease inhibitor. SLPI has been shown to be the dominant protease inhibitor in bronchial secretions and has been used in treatment of pulmonary emphysema. READ MORE
-
2. Vaginal commensal bacteria. Interactions with cervix epithelial and monocytic cells and influence on cytokines and secretory leukocyte protease inhibitor, SLPI
Abstract : Vaginal commensal bacteria Interactions with cervix epithelial and monocytic cells and influence on cytokines and secretory leukocyte protease inhibitor, SLPI Louise Strömbeck Department of Infectious Medicine, Gothenburg University Abstract Lactobacillus is the predominant species of the vaginal microbiota in women of childbearing age. Lactobacilli are thought to contribute to the local immune defence by producing a variety of antimicrobial substances and, thereby, attenuate growth of other opportunistic bacteria. READ MORE
-
3. Experimental and Clinical Studies of SLPI, with Special Reference to IgE-Mediated Allergic Reactions
Abstract : In this study we demonstrated the production of SLPI (Secretory Leukocyte Protease Inhibitor) in serous glands in the nasal mucosa. We have shown that the pattern of the expression of mRNA corresponds to the encoded protein. The encoded protein was detected by immunohistochemical methods and mRNA was discovered by in situ hybridisation. READ MORE
-
4. Serine protease inhibitors in the upper and lower airways
Abstract : Proteases and their inhibitors are implicated in the physiology and pathology of the airways. Protease inhibitors include those produced locally, such as secretory leukocyte protease inhibitor (SLPI), and those produced mainly by the liver that can reach the airways via passive diffusion, such as alpha1-antitrypsin (AAT). READ MORE
-
5. SLPI and soluble BTLA as immunological markers in severe bacterial infections
Abstract : Clinical presentation, and outcome of infections are affected by host-, and etiology- (focus of infection and pathogen) related factors. The immune response is controlled by a network of regulating pathways. READ MORE